NEW YORK (GenomeWeb) – Researchers this week shared early data from the first 100 patients in the ongoing TRACERx (Tracking Cancer Evolution through Therapy) lung cancer study, illustrating how the effort is illuminating the clonal evolution of the disease in new ways, with implications for possible new targeted and immunotherapy.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.